Literature DB >> 25040381

Glioblastoma: background, standard treatment paradigms, and supportive care considerations.

Susan V Ellor1, Teri Ann Pagano-Young, Nicholas G Avgeropoulos.   

Abstract

Glioblastoma is a brain tumor condition marked by rapid neurological and clinical demise, resulting in disproportionate disability for those affected. Caring for this group of patients is complex, intense, multidisciplinary in nature, and fraught with the need for expensive treatments, surveillance imaging, physician follow-up, and rehabilitative, psychological, and social support interventions. Few of these patients return to the workforce for any meaningful time frame, and because of the enormity of the financial burden that patients, their caregivers, and society face, utilization reviews become the focus of ethical scrutiny.
© 2014 American Society of Law, Medicine & Ethics, Inc.

Entities:  

Mesh:

Year:  2014        PMID: 25040381     DOI: 10.1111/jlme.12133

Source DB:  PubMed          Journal:  J Law Med Ethics        ISSN: 1073-1105            Impact factor:   1.718


  19 in total

1.  Tumor Microenvironment Characterization in Glioblastoma Identifies Prognostic and Immunotherapeutically Relevant Gene Signatures.

Authors:  Jinsen Zhang; Xing Xiao; Xin Zhang; Wei Hua
Journal:  J Mol Neurosci       Date:  2020-01-31       Impact factor: 3.444

2.  Introduction: Brain science in the 21st century: clinical controversies and ethical and legal implications.

Authors:  Robert M Sade
Journal:  J Law Med Ethics       Date:  2014       Impact factor: 1.718

Review 3.  Current trends in the surgical management and treatment of adult glioblastoma.

Authors:  Richard M Young; Aria Jamshidi; Gregory Davis; Jonathan H Sherman
Journal:  Ann Transl Med       Date:  2015-06

Review 4.  Brain targeted delivery of anticancer drugs: prospective approach using solid lipid nanoparticles.

Authors:  Anupriya Anand; Abimanyu Sugumaran; Damodharan Narayanasamy
Journal:  IET Nanobiotechnol       Date:  2019-06       Impact factor: 1.847

Review 5.  Glioblastoma: Overview of Disease and Treatment.

Authors:  Mary Elizabeth Davis
Journal:  Clin J Oncol Nurs       Date:  2016-10-01       Impact factor: 1.027

6.  Arginine methylation: the promise of a 'silver bullet' for brain tumours?

Authors:  Sabrina F Samuel; Antonia Barry; John Greenman; Pedro Beltran-Alvarez
Journal:  Amino Acids       Date:  2021-01-06       Impact factor: 3.520

Review 7.  Major Challenges and Potential Microenvironment-Targeted Therapies in Glioblastoma.

Authors:  Ali S Arbab; Mohammad H Rashid; Kartik Angara; Thaiz F Borin; Ping-Chang Lin; Meenu Jain; Bhagelu R Achyut
Journal:  Int J Mol Sci       Date:  2017-12-16       Impact factor: 5.923

8.  Checkpoint inhibitor immunotherapy for glioblastoma: current progress, challenges and future outlook.

Authors:  Patrick C Gedeon; Cosette D Champion; Kristen E Rhodin; Karolina Woroniecka; Hanna R Kemeny; Alexa N Bramall; Joshua D Bernstock; Bryan D Choi; John H Sampson
Journal:  Expert Rev Clin Pharmacol       Date:  2020-09-11       Impact factor: 5.045

9.  Cycloheximide promotes paraptosis induced by inhibition of cyclophilins in glioblastoma multiforme.

Authors:  Lin Wang; Justin H Gundelach; Richard J Bram
Journal:  Cell Death Dis       Date:  2017-05-18       Impact factor: 8.469

10.  Glucose-regulated protein 78 substrate-binding domain alters its conformation upon EGCG inhibitor binding to nucleotide-binding domain: Molecular dynamics studies.

Authors:  K R D Sagara N S Gurusinghe; Aanchal Mishra; Seema Mishra
Journal:  Sci Rep       Date:  2018-04-03       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.